{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T19:00:54Z","timestamp":1777662054939,"version":"3.51.4"},"reference-count":34,"publisher":"Elsevier BV","issue":"17","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Hookipa AG"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1016\/j.vaccine.2016.03.005","type":"journal-article","created":{"date-parts":[[2016,3,10]],"date-time":"2016-03-10T15:51:38Z","timestamp":1457625098000},"page":"1993-1999","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["Replication-defective lymphocytic choriomeningitis virus vectors expressing guinea pig cytomegalovirus gB and pp65 homologs are protective against congenital guinea pig cytomegalovirus infection"],"prefix":"10.1016","volume":"34","author":[{"given":"Rhonda D.","family":"Cardin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando J.","family":"Bravo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Derek A.","family":"Pullum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Klaus","family":"Orlinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth M.","family":"Watson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Aspoeck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerhard","family":"Fuhrmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farshad","family":"Guirakhoo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Monath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David I.","family":"Bernstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2016.03.005_bib0175","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0095-5108(18)30189-1","article-title":"Cytomegalovirus infection in the pregnant mother, fetus, and newborn infant","volume":"24","author":"Nelson","year":"1997","journal-title":"Clin Perinatol"},{"key":"10.1016\/j.vaccine.2016.03.005_bib0180","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1542\/peds.66.5.758","article-title":"Outcome of symptomatic congenital cytomegalovirus infection: results of long-term longitudinal follow-up","volume":"66","author":"Pass","year":"1980","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2016.03.005_bib0185","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/S0022-3476(97)70248-8","article-title":"Progressive and fluctuating sensorineural hearing loss in children with asymptomatic congenital cytomegalovirus infection","volume":"130","author":"Fowler","year":"1997","journal-title":"J Pediatr"},{"key":"10.1016\/j.vaccine.2016.03.005_bib0190","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1542\/peds.99.6.800","article-title":"Ten-year clinical, developmental, and intellectual follow-up of children with congenital cytomegalovirus infection without neurologic symptoms at one year of age","volume":"99","author":"Ivarsson","year":"1997","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2016.03.005_bib0195","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1128\/JVI.64.3.1079-1085.1990","article-title":"Cell surface expression of human cytomegalovirus (HCMV) gp 55-116 (gB): use of HCMV-recombinant vaccinia virus-infected cells in analysis of the human neutralizing antibody response","volume":"64","author":"Britt","year":"1990","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2016.03.005_bib0200","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1086\/317654","article-title":"Preconception immunization with a cytomegalovirus (CMV) glycoprotein vaccine improves pregnancy outcome in a guinea pig model of congenital CMV infection","volume":"183","author":"Bourne","year":"2001","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2016.03.005_bib0205","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1086\/382751","article-title":"Protection against congenital cytomegalovirus infection and disease in guinea pigs, conferred by a purified recombinant glycoprotein B vaccine","volume":"189","author":"Schleiss","year":"2004","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2016.03.005_bib0210","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1056\/NEJMoa0804749","article-title":"Vaccine prevention of maternal cytomegalovirus infection","volume":"360","author":"Pass","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2016.03.005_bib0215","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1086\/319680","article-title":"A canarypox vector-expressing cytomegalovirus (CMV) phosphoprotein 65 induces long-lasting cytotoxic T cell responses in human CMV-seronegative subjects","volume":"183","author":"Berencsi","year":"2001","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2016.03.005_bib0220","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.vaccine.2009.09.135","article-title":"Randomized, double-blind, Phase 1 trial of an alphavirus replicon vaccine for cytomegalovirus in CMV seronegative adult volunteers","volume":"28","author":"Bernstein","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.03.005_bib0225","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1086\/588385","article-title":"Safety and immunogenicity of a bivalent cytomegalovirus DNA vaccine in healthy adult subjects","volume":"197","author":"Wloch","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2016.03.005_bib0230","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/S1473-3099(11)70344-9","article-title":"A novel therapeutic cytomegalovirus DNA vaccine in allogeneic haemopoietic stem-cell transplantation: a randomised, double-blind, placebo-controlled, phase 2 trial","volume":"12","author":"Kharfan-Dabaja","year":"2012","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2016.03.005_bib0235","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1086\/511982","article-title":"Preconceptual administration of an alphavirus replicon UL83 (pp65 homolog) vaccine induces humoral and cellular immunity and improves pregnancy outcome in the guinea pig model of congenital cytomegalovirus infection","volume":"195","author":"Schleiss","year":"2007","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2016.03.005_bib0240","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1038\/90950","article-title":"Differential regulation of antiviral T-cell immunity results in stable CD8+ but declining CD4+ T-cell memory","volume":"7","author":"Homann","year":"2001","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2016.03.005_bib0245","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1172\/JCI200422374","article-title":"Kinetics of protective antibodies are determined by the viral surface antigen","volume":"114","author":"Pinschewer","year":"2004","journal-title":"J Clin Invest"},{"key":"10.1016\/j.vaccine.2016.03.005_bib0250","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/nm.2104","article-title":"Development of replication-defective lymphocytic choriomeningitis virus vectors for the induction of potent CD8+ T cell immunity","volume":"16","author":"Flatz","year":"2010","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2016.03.005_bib0255","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1093\/infdis\/172.4.944","article-title":"Effect of passive antibody on congenital cytomegalovirus infection in guinea pigs","volume":"172","author":"Bratcher","year":"1995","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2016.03.005_bib0260","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1093\/clinids\/5.2.177","article-title":"Cytomegaloviral infections in the guinea pig: experimental models for human disease","volume":"5","author":"Bia","year":"1983","journal-title":"Rev Infect Dis"},{"key":"10.1016\/j.vaccine.2016.03.005_bib0265","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1093\/infdis\/138.5.650","article-title":"Experimental congenital infection with cytomegalovirus: a guinea pig model","volume":"138","author":"Kumar","year":"1978","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2016.03.005_bib0270","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1093\/infdis\/172.5.1212","article-title":"Reduced congenital cytomegalovirus (CMV) infection after maternal immunization with a guinea pig CMV glycoprotein before gestational primary CMV infection in the guinea pig model","volume":"172","author":"Harrison","year":"1995","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2016.03.005_bib0275","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1086\/499603","article-title":"Effect of maternal treatment with cyclic HPMPC in the guinea pig model of congenital cytomegalovirus infection","volume":"193","author":"Bravo","year":"2006","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2016.03.005_bib0280","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1128\/AAC.00971-10","article-title":"Oral hexadecyloxypropyl-cidofovir therapy in pregnant guinea pigs improves outcome in the congenital model of cytomegalovirus infection","volume":"55","author":"Bravo","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.vaccine.2016.03.005_bib0285","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.jcv.2007.10.008","article-title":"Comparison of vaccine strategies against congenital CMV infection in the guinea pig model","volume":"41","author":"Schleiss","year":"2008","journal-title":"J Clin Virol"},{"key":"10.1016\/j.vaccine.2016.03.005_bib0290","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1086\/315022","article-title":"A subunit cytomegalovirus vaccine based on recombinant envelope glycoprotein B and a new adjuvant","volume":"180","author":"Pass","year":"1999","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2016.03.005_bib0295","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1093\/infdis\/171.1.26","article-title":"Immunity induced by primary human cytomegalovirus infection protects against secondary infection among women of childbearing age","volume":"171","author":"Adler","year":"1995","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2016.03.005_bib0300","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1016\/S0140-6736(11)60136-0","article-title":"Cytomegalovirus glycoprotein-B vaccine with MF59 adjuvant in transplant recipients: a phase 2 randomised placebo-controlled trial","volume":"377","author":"Griffiths","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2016.03.005_bib0305","doi-asserted-by":"crossref","first-page":"6980","DOI":"10.1016\/j.vaccine.2012.09.056","article-title":"The next generation recombinant human cytomegalovirus vaccine candidates-beyond gB","volume":"30","author":"Lilja","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.03.005_bib0310","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.1016\/j.vaccine.2013.07.010","article-title":"Glycoprotein B (gB) vaccines adjuvanted with AS01 or AS02 protect female guinea pigs against cytomegalovirus (CMV) viremia and offspring mortality in a CMV-challenge model","volume":"32","author":"Schleiss","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.03.005_bib0315","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1086\/379839","article-title":"Preconception vaccination with a glycoprotein B (gB) DNA vaccine protects against cytomegalovirus (CMV) transmission in the guinea pig model of congenital CMV infection","volume":"188","author":"Schleiss","year":"2003","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2016.03.005_bib0320","doi-asserted-by":"crossref","first-page":"4013","DOI":"10.1016\/j.vaccine.2015.06.019","volume":"33","author":"Swanson","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.03.005_bib0325","doi-asserted-by":"crossref","first-page":"3199","DOI":"10.1016\/j.vaccine.2013.04.078","article-title":"Effects of immunization of pregnant guinea pigs with guinea pig cytomegalovirus glycoprotein B on viral spread in the placenta","volume":"31","author":"Hashimoto","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.03.005_bib0330","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1093\/infdis\/jiu019","article-title":"Intrauterine growth restriction caused by underlying congenital cytomegalovirus infection","volume":"209","author":"Pereira","year":"2014","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2016.03.005_bib0335","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.tim.2005.02.009","article-title":"Insights into viral transmission at the uterine-placental interface","volume":"13","author":"Pereira","year":"2005","journal-title":"Trends Microbiol"},{"issue":"Suppl 4","key":"10.1016\/j.vaccine.2016.03.005_bib0340","doi-asserted-by":"crossref","first-page":"S174","DOI":"10.1093\/cid\/cit583","article-title":"Cytomegalovirus infection and antibody protection of the developing placenta","volume":"57","author":"Pereira","year":"2013","journal-title":"Clin Infect Dis"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16002838?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16002838?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,14]],"date-time":"2022-06-14T22:10:25Z","timestamp":1655244625000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X16002838"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":34,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["S0264410X16002838"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.03.005","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Replication-defective lymphocytic choriomeningitis virus vectors expressing guinea pig cytomegalovirus gB and pp65 homologs are protective against congenital guinea pig cytomegalovirus infection","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.03.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Ltd. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}